Stryker Corporation
Financials
Valuation Metrics
Stryker Corporation's Market Cap is $130.80B. At end of 2025 it was $134.44B. Ranked #128 of 3,111 in US market (top 4%), #85 of 1,666 on NYSE (top 5%), #7 of 206 in Health Care Equipment & Services (top 3%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $130.80B | US#128/3,111 Sec#7/206 |
| Revenue | $25.27B | US#261/3,111 Sec#16/206 |
| Net Income | $3.34B | US#212/3,111 Sec#11/206 |
| Total Assets | $46.29B | US#350/3,111 Sec#16/206 |
| Net Assets | $22.98B | US#220/3,111 Sec#11/206 |
| Employees | 56,000 | US#157/3,111 Sec#19/206 |
| Value | ||
| P/E | 39.20x | US#1,666/3,111 Sec#73/206 |
| P/B | 5.69x | US#2,257/3,111 Sec#146/206 |
| PEG | 2.82x | US#1,108/3,111 Sec#54/206 |
| P/S | 5.18x | US#2,276/3,111 Sec#160/206 |
| EV/EBITDA | 23.23x | US#1,963/3,111 Sec#94/206 |
| FCF Yield | 3.49% | US#1,610/3,111 Sec#92/206 |
| Profitability | ||
| ROE | 14.52% | US#903/3,111 Sec#42/206 |
| ROA | 7.21% | US#704/3,111 Sec#43/206 |
| Op. Margin | 21.34% | US#834/3,111 Sec#25/206 |
| Revenue Growth | 2.63% | US#1,988/3,111 Sec#144/206 |
| Earnings Growth | 13.91% | US#1,046/3,111 Sec#51/206 |
| Financial Health | ||
| Debt Ratio | 101.45% | US#1,114/3,111 Sec#108/206 |
| Total Debt | $15.23B | US#299/3,111 Sec#13/206 |
| FCF | $4.57B | US#160/3,111 Sec#12/206 |
| Cash | $2.88B | US#308/3,111 Sec#16/206 |
| Current Ratio | 2.11x | US#1,182/3,111 Sec#111/206 |
| Net Debt/EBITDA | 2.01x | US#1,354/3,111 Sec#82/206 |
| Dividend | ||
| Div. Yield | 0.99% | US#1,291/3,111 Sec#27/206 |
| Div. Growth | 5.00% | US#807/3,111 Sec#30/206 |
| Performance | ||
| 1Y Return | -9.26% | US#2,469/3,111 Sec#164/206 |
| 1M Return | 4.48% | US#996/3,111 Sec#82/206 |
| From 52W High | -13.62% | US#1,501/3,111 Sec#101/206 |
| 1Y MDD | -29.64% | US#1,353/3,111 Sec#49/206 |
| Trading | ||
| Volume | 2,148,880 shares | US#463/3,111 Sec#19/206 |
| Trading Value | $726M | US#65/3,111 Sec#1/206 |
| Per Share | ||
| EPS | $8.49 | US#323/3,111 Sec#24/206 |
| BPS | $58.61 | US#319/3,111 Sec#26/206 |
Company Info
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.